Healthcare

share

When it comes to figuring out a solution to the global pandemic that is COVID-19, our experts would...

share

In his 2005 best seller, “The Wisdom of Crowds,” author James Surowiecki argues for what he describes as...

share

Paul Dykewicz discusses which pharmaceutical equities might be worth considering as the COVID-19 crisis rages on.

share

(Note: third in a series on pharmaceutical ETFs) It seems like health-care-related topics and stocks are all the...

share

Olivia Faucher discusses and analyzes five factors of the current COVID-19 crisis that are currently affecting the stock...

Pfizer
share

Jim Woods discusses an exchange-traded fund (ETF) that provides access into the world of pharmaceutical stocks.

share

The buildup to second-quarter earnings season was accompanied by some steady moves higher among the leading mega-tech stocks....

share

Paul Dykewicz reveals ten alluring health care stocks to buy before the stock market recovers from the COVID-19...

share

A funny thing happened in the markets last Thursday. Well, not funny “ha ha,” but rather, funny “unusual.”...

share

Bryan Perry discusses the effects of the recent Fed stimulus package on the market. He then predicts who...